BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4036221)

  • 41. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hyperprolactinemia. Pathophysiology, clinical significance, therapy].
    Von Werder K; Fahlbusch R; Rjosk HK
    Internist (Berl); 1977 Oct; 18(10):520-8. PubMed ID: 338540
    [No Abstract]   [Full Text] [Related]  

  • 43. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of effect of hyperprolactinemia on glucose disposal and insulin secretion in patients with prolactinomas.
    Katz EJ; Donald RA; Beaven DW; Espiner EA
    Horm Metab Res; 1981 Dec; 13(12):667-9. PubMed ID: 7033092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of the role of bromocriptine in the primary treatment of prolactinomas.
    Lamberts SW
    Neth J Med; 1988 Apr; 32(3-4):107-11. PubMed ID: 3362264
    [No Abstract]   [Full Text] [Related]  

  • 47. Bromocriptine treatment of pituitary adenomas.
    Baskin DS; Wilson CB
    Neurosurgery; 1981 Jun; 8(6):741-4. PubMed ID: 7279165
    [No Abstract]   [Full Text] [Related]  

  • 48. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
    Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
    Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.
    Dietemann JL; Portha C; Cattin F; Mollet E; Bonneville JF
    Neuroradiology; 1983; 25(3):133-8. PubMed ID: 6888713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
    Ciccarelli E; Ghigo E; Mazza E; Andreis M; Massara F; Lancranjan I; Camanni F
    J Endocrinol Invest; 1987 Apr; 10(2):179-82. PubMed ID: 3584856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Results of bromocriptine treatment of giant or invasive prolactin adenomas. Apropos of 20 cases].
    Scherrer H; Turpin G; De Gennes JL; Schaison-Cusin M; Heshmati HM; Thibierge M; Metzger J
    Ann Med Interne (Paris); 1985; 136(6):459-66. PubMed ID: 4083636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
    Brismar K
    Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol Suppl (Copenh); 1978; 216():147-64. PubMed ID: 347859
    [No Abstract]   [Full Text] [Related]  

  • 54. Changes in computed tomographic findings in microprolactinomas before and after bromocriptine.
    Demura R; Kubo O; Demura H; Shizume K; Kitamura K
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):308-12. PubMed ID: 4072572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bromocriptine treatment of prolactinomas and primary hyperprolactinemia (author's transl)].
    Fossati P; Grenier JL; Stevenard C; Fermon C; Christiaens JL; Linquette M
    Ann Med Interne (Paris); 1982; 133(1):45-7. PubMed ID: 7065588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural history of patients with hyperprolactinaemia.
    Pepperell RJ; Martinez C; Dickinson A
    Clin Reprod Fertil; 1983 Dec; 2(4):237-47. PubMed ID: 6678600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of hyperprolactinemic states with different drugs: a study with bromocriptine, metergoline, and lisuride.
    Crosignani PG; Ferrari C; Liuzzi A; Benco R; Mattei A; Rampini P; Dellabonzana D; Scarduelli C; Spelta B
    Fertil Steril; 1982 Jan; 37(1):61-7. PubMed ID: 7199483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bromocriptine treatment of postoperative prolactinoma patients.
    Yang DY; Wang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):346-50. PubMed ID: 8087709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin levels in pregnancy: comparison of normal subjects with patients having micro- or macroadenomas after early bromocriptine withdrawal.
    Woodhouse NJ; Niles N; McDonald D; McCorkell S
    Horm Res; 1985; 21(1):1-9. PubMed ID: 3972334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.